Skip to main content

Ethical and Social Problems of Gene Therapy

  • Chapter
Gene Therapy

Abstract

Since the early days of gene therapy at the end of the 1980s, both the scientific community and the public have perceived the ethical and social problems intrinsic to this discipline. On one hand, the technologies for gene transfer are still largely experimental and thus pose important safety issues. On the other hand, the objective of several gene therapy applications is the stable modification of the genetic characteristics of an individual. Whether such modification is ethically acceptable and might also be applied to the embryo or fetus before birth, or to the germinal cells, has always been the subject of intense debate. Finally, while gene therapy is largely accepted when its application is to allow survival or improvement in the health of an individual, the gene transfer technologies of this discipline can also be exploited for the improvement of aesthetic appearance or physical and intellectual performance. These, and other major themes currently at the center of the ethical and social debate accompanying the development of gene therapy, are discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  • Caplan AL (2008) If it’s broken, shouldn’t it be fixed? Informed consent and initial clinical trials of gene therapy. Hum Gene Ther 19:5–6

    Article  CAS  PubMed  Google Scholar 

  • Chan S, Harris J (2006) Cognitive regeneration or enhancement: the ethical issues. Regen Med 1:361–366

    Article  PubMed  Google Scholar 

  • Chan S, Harris J (2006) The ethics of gene therapy. Curr Opin Mol Ther 8:377–383

    PubMed  Google Scholar 

  • Coutelle C, Themis M, Waddington SN et al (2005) Gene therapy progress and prospects: fetal gene therapy — first proofs of concept — some adverse effects. Gene Ther 12:1601–1607

    Article  CAS  PubMed  Google Scholar 

  • Deakin CT, Alexander IE, Kerridge I (2009) Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther 17:1842–1848

    Article  CAS  PubMed  Google Scholar 

  • Harris J, Chan S (2008) Enhancement is good for you!: understanding the ethics of genetic enhancement. Gene Ther 15:338–339

    Article  CAS  PubMed  Google Scholar 

  • Kahn J (2008) Informed consent in human gene transfer clinical trials. Hum Gene Ther 19:7–8

    Article  CAS  PubMed  Google Scholar 

  • Kiuru M, Crystal RG (2008) Progress and prospects: gene therapy for performance and appearance enhancement. Gene Ther 15:329–337

    Article  CAS  PubMed  Google Scholar 

  • Spink J, Geddes D (2004) Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment. Gene Ther 11:1611–1616

    Article  CAS  PubMed  Google Scholar 

  • Wells DJ (2008) Gene doping: the hype and the reality. Br J Pharmacol 154:623–631

    Article  CAS  PubMed  Google Scholar 

Selected Bibliography

  • Batshaw ML, Wilson JM, Raper S et al (1999) Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD). Hum Gene Ther 10:2419–2437

    Article  CAS  PubMed  Google Scholar 

  • Frank KM, Hogarth DK, Miller JL et al (2009) Investigation of the cause of death in a gene-therapy trial. N Engl J Med 361:161–169

    Article  CAS  PubMed  Google Scholar 

  • Grimm D, Streetz KL, Jopling CL et al (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537–541

    Article  CAS  PubMed  Google Scholar 

  • Kaiser J (2007) Clinical research. Death prompts a review of gene therapy vector. Science 317:580

    Article  CAS  PubMed  Google Scholar 

  • Reay DP, Bilbao R, Koppanati BM et al (2008) Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 15:531–536

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Italia

About this chapter

Cite this chapter

Giacca, M. (2010). Ethical and Social Problems of Gene Therapy. In: Gene Therapy. Springer, Milano. https://doi.org/10.1007/978-88-470-1643-9_5

Download citation

Publish with us

Policies and ethics